torsemide has been researched along with Fibrosis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arumugam, S; Harima, M; Karuppagounder, V; Nakamura, M; Sone, H; Sreedhar, R; Suzuki, H; Watanabe, K | 1 |
| Anstrom, KJ; Buggey, J; Eisenstein, EL; Mentz, RJ; O'Connor, CM; Pitt, B; Velazquez, EJ | 1 |
| Adam, O; Böhm, M; Hanke, N; Hartmann, RW; Klemmer, B; Laufs, U; Zimmer, C | 1 |
| Díez, J; Weber, KT | 1 |
| Díez, J; González, A; Hermida, N; Laviades, C; López, B | 1 |
| Lyseng-Williamson, KA | 1 |
| Anguita, M; Castro-Beiras, A; Cobo, E; Coca, A; Conthe, P; de Teresa, E; Díez, J; Fernández, E | 1 |
| Yamamoto, T; Yano, M | 1 |
| Beaumont, J; Díez, J; González, A; Larman, M; López, B; Querejeta, R | 1 |
4 review(s) available for torsemide and Fibrosis
| Article | Year |
|---|---|
A reappraisal of loop diuretic choice in heart failure patients.
Topics: Choice Behavior; Fibrosis; Furosemide; Heart; Heart Failure; Humans; Myocardium; Practice Patterns, Physicians'; Renin-Angiotensin System; Sodium Potassium Chloride Symporter Inhibitors; Sulfonamides; Torsemide; Up-Regulation; Ventricular Dysfunction, Left | 2015 |
Myocardial fibrosis in chronic kidney disease: potential benefits of torasemide.
Topics: Chronic Disease; Diuretics; Fibrosis; Heart Diseases; Humans; Kidney Diseases; Myocardium; Risk Factors; Sulfonamides; Torsemide | 2008 |
Torasemide prolonged release.
Topics: Animals; Antihypertensive Agents; Delayed-Action Preparations; Diuretics; Drug Interactions; Fibrosis; Humans; Hypertension; Intestinal Absorption; Sulfonamides; Therapeutic Equivalency; Torsemide | 2009 |
[Aldosterone antagonist therapy for chronic heart failure].
Topics: Aldosterone; Chronic Disease; Death, Sudden, Cardiac; Diuretics; Eplerenone; Fibrosis; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Myocardium; Randomized Controlled Trials as Topic; Spironolactone; Sulfonamides; Torsemide; Ventricular Remodeling | 2005 |
3 trial(s) available for torsemide and Fibrosis
| Article | Year |
|---|---|
TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure.
Topics: Chronic Disease; Collagen Type I; Delayed-Action Preparations; Diuretics; Female; Fibrosis; Furosemide; Heart Failure; Humans; Male; Peptide Fragments; Procollagen; Prospective Studies; Research Design; Sulfonamides; Torsemide | 2009 |
Effects of prolonged-release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study.
Topics: Aged; Biomarkers; Chronic Disease; Delayed-Action Preparations; Diuretics; Endpoint Determination; Female; Fibrosis; Furosemide; Heart Failure; Humans; Hypertension; Male; Myocardium; Peptide Fragments; Procollagen; Prospective Studies; Sulfonamides; Torsemide; Treatment Outcome | 2011 |
Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure.
Topics: Adult; Aged; Antihypertensive Agents; Blotting, Western; Endocardium; Extracellular Matrix; Female; Fibrosis; Furosemide; Heart; Heart Failure; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Male; Middle Aged; Myocardium; Peptide Fragments; Pilot Projects; Procollagen; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Torsemide | 2007 |
3 other study(ies) available for torsemide and Fibrosis
| Article | Year |
|---|---|
Comparative evaluation of torasemide and spironolactone on adverse cardiac remodeling in a rat model of dilated cardiomyopathy.
Topics: Animals; Autoimmunity; Biomarkers; Cardiac Myosins; Cardiomyopathy, Dilated; Disease Models, Animal; Endoplasmic Reticulum Stress; Fibrosis; Heart Ventricles; Male; Mineralocorticoid Receptor Antagonists; Myocarditis; Rats, Inbred Lew; Sodium Potassium Chloride Symporter Inhibitors; Spironolactone; Sulfonamides; Torsemide; Ventricular Function, Left; Ventricular Remodeling | 2017 |
Inhibition of aldosterone synthase (CYP11B2) by torasemide prevents atrial fibrosis and atrial fibrillation in mice.
Topics: Aldosterone; Animals; Atrial Fibrillation; Atrial Remodeling; Cardiotonic Agents; Cells, Cultured; Connective Tissue Growth Factor; Cytochrome P-450 CYP11B2; Drug Evaluation, Preclinical; Fibrillar Collagens; Fibroblasts; Fibrosis; Inhibitory Concentration 50; Mice; Mice, Transgenic; MicroRNAs; Protein-Lysine 6-Oxidase; Rats, Sprague-Dawley; Sulfonamides; Torsemide | 2015 |
Targeting the Cardiac Myofibroblast Secretome to Treat Myocardial Fibrosis in Heart Failure.
Topics: Animals; Cardiovascular Agents; Clinical Decision-Making; Fibrosis; Heart Failure; Humans; Molecular Targeted Therapy; Myocardium; Myofibroblasts; Patient Selection; Precision Medicine; Proteins; Sulfonamides; Torsemide; Ventricular Remodeling | 2016 |